Headache Relief Extra Strength

Generic: Acetaminophen, Aspirin, Caffeine

Labeler: Rite Aid Corporation
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive

Drug Facts

Product Profile

Brand Name Headache Relief Extra Strength
Generic Name Acetaminophen, Aspirin, Caffeine
Labeler Rite Aid Corporation
Dosage Form TABLET
Routes
ORAL
Active Ingredients

ACETAMINOPHEN 250 mg/1, ASPIRIN 250 mg/1, CAFFEINE 65 mg/1

Identifiers & Regulatory

Product NDC 11822-7888
Product ID 11822-7888_06d7ca6c-0c4f-4d76-b147-1201a9e3ed8d
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M013
Marketing Start 2020-02-28
Marketing End 2026-02-28

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 118227888
Hyphenated Format 11822-7888

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name Headache Relief Extra Strength (source: ndc)
Generic Name Acetaminophen, Aspirin, Caffeine (source: ndc)
Application Number M013 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
  • 65 mg/1
source: ndc
Packaging
  • 1 BOTTLE, PLASTIC in 1 BOX (11822-7888-4) / 20 TABLET in 1 BOTTLE, PLASTIC
  • 1 BOTTLE, PLASTIC in 1 BOX (11822-7888-5) / 80 TABLET in 1 BOTTLE, PLASTIC
source: ndc

Packages (2)

Ingredients (3)

ACETAMINOPHEN (250 mg/1) ASPIRIN (250 mg/1) CAFFEINE (65 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "06d7ca6c-0c4f-4d76-b147-1201a9e3ed8d", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "upc": ["0011822788472"], "unii": ["362O9ITL9D", "R16CO5Y76E", "3G6A5W338E"], "rxcui": ["308297"], "spl_set_id": ["510f35bb-a439-4ee5-9111-166a3b240cc1"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Rite Aid Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 BOX (11822-7888-4)  / 20 TABLET in 1 BOTTLE, PLASTIC", "package_ndc": "11822-7888-4", "marketing_end_date": "20260228", "marketing_start_date": "20200228"}, {"sample": false, "description": "1 BOTTLE, PLASTIC in 1 BOX (11822-7888-5)  / 80 TABLET in 1 BOTTLE, PLASTIC", "package_ndc": "11822-7888-5", "marketing_end_date": "20260228", "marketing_start_date": "20200228"}], "brand_name": "Headache Relief Extra Strength", "product_id": "11822-7888_06d7ca6c-0c4f-4d76-b147-1201a9e3ed8d", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "11822-7888", "generic_name": "Acetaminophen, Aspirin, Caffeine", "labeler_name": "Rite Aid Corporation", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Headache Relief", "brand_name_suffix": "Extra Strength", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "250 mg/1"}, {"name": "ASPIRIN", "strength": "250 mg/1"}, {"name": "CAFFEINE", "strength": "65 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_end_date": "20260228", "marketing_start_date": "20200228"}